Epithelial neutrophil localization and tight junction Claudin‐2 expression are innovative outcome predictors in inflammatory bowel disease

Irene Zammarchi(APC Microbiome Institute), Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust)

United European Gastroenterology Journal

October 3, 2024

10.1002/ueg2.12677

Cited by 15

Related Papers

Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease

|Alimentary Pharmacology & Therapeutics|2019|155

Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study

|Inflammatory Bowel Diseases|2022|44